TMCnet News
GenMark Diagnostics to Present at the 36th Annual Canaccord Genuity Growth Conference
GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of
automated, multiplex molecular diagnostic testing systems, announced
today that Hany Massarany, President and Chief Executive Officer, will
present at the 36th Annual Canaccord Genuity Growth Conference to be
held in Boston, Massachusetts at the InterContinental Hotel on
Wednesday, August 10, 2016 at 8:30 a.m. Eastern Time. The presentation
will be made available at http ABOUT GENMARK DIAGNOSTICS GenMark Diagnostics (NASDAQ: GNMK) is a leading provider of automated, multiplex molecular diagnostic testing systems that detect and measure DNA and RNA targets to diagnose disease and optimize patient treatment. Utilizing GenMark's proprietary eSensor® detection technology, GenMark's eSensor XT-8® system is designed to support a broad range of molecular diagnostic tests with a compact, easy-to-use workstation and self-contained, disposable test cartridges. The eSensor detection technology is also incorporated into GenMark's sample-to-answer system, ePlex®. For more information, visit www.genmarkdx.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160727006635/en/ |
